Michael R. Hayden

Last updated
Michael R. Hayden
MRH-wiki-photo.jpg
Born1951
Alma mater Harvard University
University of Cape Town
Awards Humanitarian Award (2020)
Inductee, Canadian Medical Hall of Fame (2017)
Gairdner Foundation Wightman Award (2011)
Order of Canada (2010)
Order of British Columbia (2009)
Canada's Health Researcher of the Year - Biomedical and Clinical Research, Canadian Institutes for Health Research CIHR (2008)
Scientific career
Fields Medical genetics, human genetics, personalized medicine
Institutions Centre for Molecular Medicine and Therapeutics, Child & Family Research Institute, University of British Columbia
British Columbia's Children's Hospital
British Columbia's Children's Hospital
Provincial Health Services Authority

Michael R. Hayden, CM OBC FRSC [1] (born 1951) [1] is a Killam Professor of Medical Genetics at the University of British Columbia, the highest honour UBC can confer on any faculty member.[ citation needed ] Only four such awards have ever been conferred in the Faculty of Medicine.[ citation needed ] Dr. Hayden is also Canada Research Chair in Human Genetics and Molecular Medicine. Hayden is best known for his research in Huntington disease (HD).

Contents

He is a senior scientist and former director of the Centre for Molecular Medicine and Therapeutics (CMMT) in Vancouver, British Columbia, Canada; a genetic research centre within UBC's Faculty of Medicine and affiliated with the BC Children's Hospital Research Institute and the BC Children's Hospital Foundation, which he founded. He was also the Program Director of the Translational Laboratory in Genetic Medicine in Singapore from 2011 to 2020, and was appointed as the President of Global R&D and Chief Scientific Officer at Teva Pharmaceutical Industries from 2012 to 2017. [2] [3] During this time, approximately 35 new products were approved in major markets with many for diseases of the central nervous system and led the approval of Austedo for chorea in HD, the second drug ever to be approved for HD. In 2015, Teva R&D was recognized as one of the 10 most exciting innovators in Pharma by IDEA Pharma and in 2017, Teva R&D ranked top of the industry for CNS development and clinical trial success by Pharma Intelligence.

Hayden is the most cited author in the world for Huntington disease and ABCA1, and has authored over 900 publications and invited submissions (Google Scholar citations 99,672, h-index 160, i10-index 766; [4] Web of Science citations 65,327, h-index 123).

In 2007, he received the Prix Galien which recognizes the outstanding contribution of a researcher to Canadian pharmaceutical research; in 2008, recognition from the Canadian Institutes of Health Research (CIHR) as Canada's Health Researcher of the Year: CIHR Michael Smith Prizes in Health Research. [5] In 2010, he was awarded Member of the Order of Canada, [6] following his receipt of the Order of British Columbia in 2009. Hayden received the Canada Gairdner Foundation Wightman Award [7] in 2011, recognizing him as a physician-scientist who has demonstrated outstanding leadership in medicine and medical science. He was inducted into the Canadian Medical Hall of Fame in 2017. [8] Most recently in 2020, Hayden was awarded the David Dubinsky Humanitarian Award from the American Friends of Soroka Medical Center (AFSMC). In addition to his academic work, Hayden is the co-founder of five biotechnology companies including: Prilenia, NeuroVir Therapeutics Inc., Xenon Pharmaceuticals Inc., Aspreva Pharmaceuticals Corp and 89Bio and the CEO of Prilenia Therapeutics. He currently sits on different public and private boards of biotechnologies companies.

Biography

Hayden was born in Cape Town, South Africa, one of Ann Platt's and Roger Hayden's two sons. His paternal grandfather, Max Raphael Hahn was an entrepreneur, art collector and chairman of the Jewish community in Göttingen, Germany. His father, originally named Rudolf (Rudi) Hahn, fled to London in 1939, enlisted in the British army and fought during World War II, and eventually settled in South Africa in 1947. [9] [10] After the divorce of his parents, when he was eight, Hayden was raised by his single mother. [1] He originally planned on becoming a lawyer but instead opted for medical school, as he soon realized that as a lawyer he would not be able to bring about much change. In 1975, he graduated from the University of Cape Town as the top graduate in medicine, where he also received his PhD in Genetics (1979). He completed a post-doctoral fellowship and further training in Internal Medicine at Harvard Medical School. Michael is board-certified in both Internal Medicine and Clinical Genetics. He moved to Canada and joined the University of British Columbia (UBC) in 1983 from the Children's Hospital in Boston, a teaching arm of Harvard Medical School.[ citation needed ]

He is married and has four children.

Science

Hayden's research focus is primarily on genetic diseases, including genetics of lipoprotein disorders, Huntington disease, predictive medicine, personalized medicine and drug development. Along with his research team, Hayden has identified 10 disease-causing genes, which includes the identification of the major gene underlying high-density lipoprotein (HDL) in humans. This gene, known as ABCA1, has major implications for atherosclerosis and diabetes. Hayden also identified the first mutations underlying Lipoprotein lipase deficiency (LPL) and developed gene therapy approaches to treat this condition, the first approved gene therapy in the western world. He is also co-leader of the Canadian Pharmacogenomics Network for Drug Safety project, a BC-led Genome Canada-funded, national strategy to prevent adverse drug reactions.[ citation needed ]

Honours

OBC ribbon Order British Columbia ribbon bar.svg
OBC ribbon

Since 2010:

Art and Science

In 2002, Hayden was part of the cast of the documentary Chasing the Cure which discussed treatments for widespread killer-heart disease, cancer, and bacterial poisoning and how research findings will change the face of medicine in the next 20 years. [24]

Hayden appears in the 2012 documentary movie Do You Really Want to Know? directed by John Zaritsky. In the film, Hayden describes his professional relationship and friendship with Huntington's disease family member and researcher Jeff Carroll and the process of guiding Carroll and his five siblings through genetic testing for the mutation that causes Huntington's. [25]

Hayden is also a subject in the 2013 documentary, "Alive & Well", directed by Josh Taft. In the film, he discusses his mission to find a cure for Huntington's disease.

See also

Related Research Articles

<span class="mw-page-title-main">Michael Smith (chemist)</span> British-born Canadian biochemist, businessman and Nobel Prize laureate (1932–2000)

Michael Smith was a British-born Canadian biochemist and businessman. He shared the 1993 Nobel Prize in Chemistry with Kary Mullis for his work in developing site-directed mutagenesis. Following a PhD in 1956 from the University of Manchester, he undertook postdoctoral research with Har Gobind Khorana at the British Columbia Research Council in Vancouver, British Columbia, Canada. Subsequently, Smith worked at the Fisheries Research Board of Canada Laboratory in Vancouver before being appointed a professor of biochemistry in the UBC Faculty of Medicine in 1966. Smith's career included roles as the founding director of the UBC Biotechnology Laboratory and the founding scientific leader of the Protein Engineering Network of Centres of Excellence (PENCE). In 1996 he was named Peter Wall Distinguished Professor of Biotechnology. Subsequently, he became the founding director of the Genome Sequencing Centre at the BC Cancer Research Centre.

<span class="mw-page-title-main">H. Robert Horvitz</span> American biologist

Howard Robert Horvitz ForMemRS NAS AAA&S APS NAM is an American biologist best known for his research on the nematode worm Caenorhabditis elegans, for which he was awarded the 2002 Nobel Prize in Physiology or Medicine, together with Sydney Brenner and John E. Sulston, whose "seminal discoveries concerning the genetic regulation of organ development and programmed cell death" were "important for medical research and have shed new light on the pathogenesis of many diseases".

<span class="mw-page-title-main">Joseph L. Goldstein</span> American biochemist

Joseph Leonard Goldstein ForMemRS is an American biochemist. He received the Nobel Prize in Physiology or Medicine in 1985, along with fellow University of Texas Southwestern researcher, Michael Brown, for their studies regarding cholesterol. They discovered that human cells have low-density lipoprotein (LDL) receptors that remove cholesterol from the blood and that when LDL receptors are not present in sufficient numbers, individuals develop hypercholesterolemia and become at risk for cholesterol related diseases, notably coronary heart disease. Their studies led to the development of statin drugs.

<span class="mw-page-title-main">Oliver Smithies</span> British-American geneticist (1925–2017)

Oliver Smithies was a British-American geneticist and physical biochemist. He is known for introducing starch as a medium for gel electrophoresis in 1955, and for the discovery, simultaneously with Mario Capecchi and Martin Evans, of the technique of homologous recombination of transgenic DNA with genomic DNA, a much more reliable method of altering animal genomes than previously used, and the technique behind gene targeting and knockout mice. He received the Nobel Prize in Physiology or Medicine in 2007 for his genetics work.

Judith Goslin Hall is a pediatrician, clinical geneticist and dysmorphologist who is a dual citizen of the United States and Canada.

Connie Jean Eaves, CorrFRSE, is a Canadian biologist with significant contributions to cancer and stem cell research. Eaves is a professor generics of genetics at the University of British Columbia and is also the co-founder with Allen C Eaves of Terry Fox Laboratory.

<span class="mw-page-title-main">National Core for Neuroethics</span>

The National Core for Neuroethics at the University of British Columbia was established in August 2007, with support from the Canadian Institutes of Health Research, the Institute of Mental Health and Addiction, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, the Canada Research Chairs program, the UBC Brain Research Centre and the UBC Institute of Mental Health. Co-founded by Judy Illes and Peter Reiner, the Core studies neuroethics, with particular focus on ethics in neurodegenerative disease and regenerative medicine, international and cross-cultural challenges in brain research, neuroimaging and ethics, the neuroethics of enhancement, and personalized medicine.

<span class="mw-page-title-main">Huda Zoghbi</span> Lebanese scientist

Huda Yahya Zoghbi, born Huda El-Hibri, is a Lebanese-born American geneticist, and a professor at the Departments of Molecular and Human Genetics, Neuroscience and Neurology at the Baylor College of Medicine. She is the director of the Jan and Dan Duncan Neurological Research Institute. She became the editor of the Annual Review of Neuroscience as of 2018.

Alan Bernstein is Professor Emeritus at the University of Toronto and President Emeritus of CIFAR, where he served as President and CEO from 2012 to 2022. A Distinguished Fellow at the Munk School of Global Affairs and Public Policy, he is also a Fellow and Member of the Standing Committee for Science Planning at the International Science Council (2022-2025). Bernstein is recognized as a leader in health research, science policy, mentorship and organizational leadership.

The Centre for Molecular Medicine and Therapeutics (CMMT) is part of the University of British Columbia's Faculty of Medicine. The Centre is located at the British Columbia Children's Hospital Research Institute (BCCHR) in Vancouver, British Columbia, Canada. Research at CMMT is focused on discovering genetic susceptibility to illnesses such as Huntington Disease, Type 2 diabetes and bipolar disorder.

<span class="mw-page-title-main">Jeff Carroll</span>

Jeffrey Bryan Carroll is an American scientific researcher in the field of Huntington's disease (HD). As a carrier of the abnormal gene that causes HD, he is also a public advocate for families affected by the disease, and co-founder of the HD research news platform HDBuzz. His life and work were the subject of a 2011 Gemini award-nominated CBC documentary feature. Carroll is an Associate Professor of neuroscience in the Department of Psychology at Western Washington University.

The UBC Faculty of Medicine is the medical school of the University of British Columbia. It is one of 17 medical schools in Canada and the only one in the province of British Columbia. It has Canada's largest undergraduate medical education program and the fifth-largest in the U.S. and Canada. It is ranked as the 2nd best medical program in Canada by Maclean's, and 27th in the world by the 2017 QS World University Rankings.

<i>Do You Really Want to Know?</i> 2012 Canadian film

Do You Really Want To Know? is a 2012 documentary film directed by John Zaritsky and produced by Kevin Eastwood. Using interviews and dramatic recreations, the film recounts the stories of three families who carry the gene for Huntington's disease, a neurodegenerative illness which is the result of a genetic abnormality, whose symptoms typically appear in mid-life. Members of each featured family have undergone predictive testing to learn whether or not they have inherited the gene that causes the disease, and they each describe the impact that testing has had upon their lives. "Do You Really Want To Know?" had its world premiere in Canada at the 2012 DOXA Documentary Film Festival and its broadcast premiere on November 13, 2012 on Knowledge Network.

Aubrey Tingle is professor emeritus in the Department of Pediatrics at the University of British Columbia (UBC) and chair of the board of directors at the Maternal, Infant, Child and Youth Research Network. In March 2001, Tingle was appointed the first president and CEO of The Michael Smith Foundation for Health Research (MSFHR).

Institute for Medical Research, Israel-Canada (IMRIC) is a research institute affiliated with the Faculty of Medicine of the Hebrew University of Jerusalem.

B. Brett Finlay, is a Canadian microbiologist well known for his contributions to understanding how microbes cause disease in people and developing new tools for fighting infections, as well as the role the microbiota plays in human health and disease. Science.ca describes him as one of the world's foremost experts on the molecular understanding of the ways bacteria infect their hosts. He also led the SARS Accelerated Vaccine Initiative (SAVI) and developed vaccines to SARS and a bovine vaccine to E. coli O157:H7. His current research interests focus on pathogenic E. coli and Salmonella pathogenicity, and the role of the microbiota in infections, asthma, and malnutrition. He is currently the UBC Peter Wall Distinguished Professor and a Professor in the Michael Smith Laboratories, Microbiology and Immunology, and Biochemistry and Molecular Biology, and Co-director and Senior Fellow for the CIFAR Humans and Microbes program. He is also co-author of the book Let Them Eat Dirt: Saving Your Child from an Oversanitized World and The Whole-Body Microbiome: How to Harness Microbes - Inside and Out - For Lifelong Health. Finlay is the author of over 500 publications in peer-reviewed journals and served as editor of several professional publications for many years.

<span class="mw-page-title-main">Robert E. W. Hancock</span>

Robert Ernest William Hancock is a Canadian microbiologist and University of British Columbia Killam Professor of Microbiology and Immunology, an Associate Faculty Member of the Wellcome Trust Sanger Institute, and a Canada Research Chair in Health and Genomics.

Gina Suzanne Ogilvie is a Canadian global and public health physician. She is a Tier 1 Canada Research Chair in Global Control of HPV related diseases and prevention, and Professor at the University of British Columbia in their School of Population and Public Health.

Pieter Rutter Cullis is a Canadian physicist and biochemist known for his contributions to the field of lipid nanoparticles (LNP). Lipid nanoparticles are essential to current mRNA vaccines as a delivery system. Prof. Cullis is best known for the development of ionizable cationic lipids. These lipids are able to complex with negatively charged nucleic acids at low pH (≈4.0) where they are positively charged because they have a pKa if approximately 6.4. They reduce or eliminate toxicity associated with cationic lipids at physiological pH of 7.4 because they adopt a net neutral charge. Finally, they enable endosomal escape because they again become positively charged in acidified endosomes and promote formation of non-bilayer structures by interaction with negatively charged lipids. These properties are critical to the function of the mRNA vaccines and are rapidly enabling gene therapy in clinical settings.

Jehannine Claire Austin is a Canadian neuropsychiatric geneticist and a genetic counselor. They are a professor at the University of British Columbia and Executive Director of the Provincial Health Services Authority's BC Mental Health and Substance Use Services Research Institute. In 2012, Austin founded the world’s first specialist psychiatric genetic counselling service.

References

  1. 1 2 3 Claudia Cornwall (Apr 1, 2008). "Michael Hayden: In The Genes". BCBusiness..
  2. Teva Pharmaceutical Industries. (2012). "Dr. Michael Hayden". Teva Pharmaceutical Industries, Ltd. Archived from the original on 2012-08-23. Retrieved 2012-09-17.
  3. George, John (21 July 2014). "Teva completes deal for second migraine-treatment developer". Phila. Bus. J. Retrieved 21 July 2014.
  4. "Michael Hayden - Google Scholar Citations". scholar.google.ca. Retrieved 2017-03-31.
  5. CIHR (2012). "Michael Hayden". Canadian Institutes of Health Research (CIHR). Archived from the original on 2013-03-19. Retrieved 2012-09-18.
  6. Marie-Eve Letourneau (December 30, 2010). "Appointments to the Order of Canada". The Governor General of Canada. Retrieved 2011-05-12.
  7. Gairdner Foundation (2011). "Michael Hayden". Canada Gairdner Foundation. Retrieved 2011-05-12.
  8. "Induction Ceremony | Canadian Medical Hall of Fame". cdnmedhall.org. Retrieved 2017-03-31.
  9. Anna Silman (June 22, 2015). "How One of the World's Leading Geneticists Recovered His Family's Stolen Legacy". Tablet .
  10. "German Jewish family recovers their history and family treasures". Cape Jewish Chronicle. March 17, 2017.
  11. "Michael Hayden receives Soroka Humanitarian Award | UBC Faculty of Medicine". www.med.ubc.ca/news. 4 November 2020. Retrieved 2021-11-04.
  12. "ANNOUNCING THE 2017 INDUCTEES | Canadian Medical Hall of Fame". cdnmedhall.org. Retrieved 2017-03-31.
  13. "ANNOUNCING THE 2017 INDUCTEES | Canadian Medical Hall of Fame". cdnmedhall.org. Retrieved 2017-03-31.
  14. "BC Children's Hospital Research Institute". www.facebook.com. Retrieved 2017-03-31.
  15. "Personalized Medicine World Conference Luminary Award Granted to Dr. Michael Hayden". www.businesswire.com. 23 June 2014. Retrieved 2017-03-31.
  16. "50 Canadians Who Changed The World - Ken McGoogan". HarperCollins Canada. Retrieved 2017-03-31.
  17. "The Governor General of Canada".
  18. "Canada Council awards five prominent scholars $100,000 Killam Prizes | The Canada Council for the Arts". canadacouncil.ca. Archived from the original on 2015-12-17.
  19. "Dr. Michael Hayden awarded Aubrey J. Tingle Prize | Michael Smith Foundation for Health Research". www.msfhr.org. Retrieved 2017-03-31.
  20. "UBC recognizes two Canadian medical researchers with $50,000 prizes". UBC News. 2011-04-21. Retrieved 2017-03-31.
  21. "Gairdner Foundation | Index of Winners". gairdner.org. Retrieved 2017-03-31.
  22. "UBC members recognized in Life Sciences BC awards". UBC News. 2013-03-05. Retrieved 2017-03-31.
  23. "The Governor General of Canada" . Retrieved 2017-03-31.
  24. "Chasing the Cure (TV Series 2002– ) - IMDb". IMDb .
  25. "Do You Really Want To Know? Official homepage" . Retrieved 2 February 2013.